Read the full article here.
Carcinotech’s founder Ishani Malhotra shortlisted as the finalist of Converge Kickstart Challenge
About Us
Carcinotech has pioneered the development of assay-ready, 3D-bioprinted tumours derived from patient biopsies for oncology drug discovery and development.